Your browser doesn't support javascript.
loading
Bevacizumab Allows Preservation of Liver Function and its Regenerative Capacity after Major Hepatectomy.
Valverde, Amparo; Ciria, Rubén; Caballero-Villarraso, Javier; Aguilar-Melero, Patricia; Ferrín, Gustavo; Ranchal, Isidora; Linares, Clara; Herencia, Carmen; González-Rubio, Sandra; de la Mata, Manuel; Naranjo, Álvaro; Briceño, Javier.
Afiliación
  • Valverde A; Unit of Hepatobiliary Surgery and Liver Transplantation, IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain.
  • Ciria R; Unit of Hepatobiliary Surgery and Liver Transplantation, IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain.
  • Caballero-Villarraso J; Clinical Analyses Service & Department of Biochemistry and Molecular Biology, IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain.
  • Aguilar-Melero P; Liver Research Unit, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain.
  • Ferrín G; Liver Research Unit, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain.
  • Ranchal I; Liver Research Unit, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain.
  • Linares C; Liver Research Unit, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain.
  • Herencia C; Liver Research Unit, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain.
  • González-Rubio S; Liver Research Unit, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain.
  • de la Mata M; Liver Research Unit, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain.
  • Naranjo Á; Unit of Hepatobiliary Surgery and Liver Transplantation, IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain.
  • Briceño J; Unit of Hepatobiliary Surgery and Liver Transplantation, IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain.
Anticancer Agents Med Chem ; 19(11): 1388-1398, 2019.
Article en En | MEDLINE | ID: mdl-31038079

Texto completo: 1 Colección: 01-internacional Asunto principal: Bevacizumab / Hepatectomía / Hígado Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Anticancer Agents Med Chem Asunto de la revista: ANTINEOPLASICOS / QUIMICA Año: 2019 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Asunto principal: Bevacizumab / Hepatectomía / Hígado Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Anticancer Agents Med Chem Asunto de la revista: ANTINEOPLASICOS / QUIMICA Año: 2019 Tipo del documento: Article País de afiliación: España